The evidence on the practice of remimazolam besylate during cardiac anesthesia is scarce. This study investigates the efficacy and safety of remimazolam besylate general induction and maintenance during cardiac surgery.
Elective cardiac surgery via cardiopulmonary bypass;
Aged 18-65 years;
American Society of Anesthesiologists (ASA) grade I-III;
Body mass index (BMI) 18-28 kg/m2.
A history of sternotomy for heart disease;
Angina or arrhythmia with severe dynamics flutters pre-operation;
Respiratory, hepatic or renal dysfunction (oxygenation index<300, alanine transaminase> 2 upper limits of normal value, creatinine > 200 μmol/L);
Diagnosed with advanced tumors;